Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.

Diabetes/metabolism research and reviews - 1 Feb 2008

Mertens Ilse, Lemieux Isabelle, Verrijken An, Després Jean-Pierre, Van Gaal Luc F

Abstract excerpt

BACKGROUND: Levels of fibrinogen, von Willebrand factor (vWF) and plasminogen activator inhibitor-1 (PAI-1) have been associated with small low-density lipoprotein (LDL) particles. However, it is not clear whether these associations are independent of visceral adiposity or other components of the metabolic syndrome such as triglycerides or insulin resistance. METHODS: Visceral adipose tissue (VAT; CT-scan),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins B
Share to Fibrinogen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyperinsulinism

Share to Intra-Abdominal Fat

Share to Lipoproteins, LDL

Share to Particle Size

Share to Plasminogen Activator Inhibitor 1

Share to von Willebrand Factor

Source

Identifiers

PMID: 17922472
DOI: 10.1002/dmrr.779

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.PMID 17922472Read ↗

Association of plasminogen activator inhibitor-1 4G/5G gene polymorphism with variations in the LDL particle size in healthy Japanese men.Semantic proximity Read ↗

The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.Semantic proximity Read ↗

Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women.Semantic proximity Read ↗

Low-density lipoprotein particle size and coronary artery disease in a childhood-onset type 1 diabetes population.Semantic proximity Read ↗

The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.Semantic proximity Read ↗

Smaller, denser LDL particles are not a risk factor for cardiovascular disease in healthy nonagenarian women of the Cremona Population Study.Semantic proximity Read ↗

Relationship between lipoprotein(a) phenotypes and plaminogen activator inhibitor type 1 in diabetic patients.Semantic proximity Read ↗

Angiographically-assessed coronary artery disease associates with HDL particle size in women.Semantic proximity Read ↗

Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study.Semantic proximity Read ↗

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease.Semantic proximity Read ↗

Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes.Semantic proximity Read ↗

LDL size and risk of coronary heart disease in elderly men and women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.